Jamaican Dogwood (Piscidia piscipula)

Jamaican Dogwood (Piscidia piscipula) contains rotenone, ichthynone, and isoflavonoids such as piscidone and jamaicin, which are thought to exert sedative and analgesic effects by modulating GABAergic pathways and inhibiting prostaglandin synthesis. It has been used in traditional herbal medicine primarily to relieve nerve pain, promote sleep, and ease anxiety, though robust human clinical evidence remains absent.

Origin & History

Jamaican Dogwood (Piscidia piscipula) is a tree native to Jamaica and Central America, with medicinal use primarily from its root bark. The bark is harvested, dried, and processed into liquid extracts, tinctures, teas, or powdered root bark pieces (1-2 inches long, 1/8 inch thick), with chemical constituents varying by geographic region.

Historical & Cultural Context

Jamaican Dogwood bark has been used in traditional medicine since the early 1800s for treating nerve pain, migraines, insomnia, anxiety, and muscle spasms, as documented in an 1832 report (PMID: 30495763). The practice stems from Caribbean/Jamaican herbal traditions spanning over 200 years.

Health Benefits

• May help with nerve pain relief (Traditional use only - no clinical trials available)
• Potentially supports sleep and reduces insomnia (Traditional use only - no clinical trials available)
• May reduce anxiety and nervous tension (Traditional use only - no clinical trials available)
• Possibly helps with migraine management (Traditional use only - no clinical trials available)
• May provide muscle spasm relief (Animal studies only - no human clinical evidence)

How It Works

The isoflavonoids piscidone and jamaicin found in Jamaican Dogwood bark are believed to potentiate GABA-A receptor activity, producing sedative and anxiolytic effects similar in principle to benzodiazepines but via distinct binding interactions. Rotenone, another key constituent, inhibits mitochondrial complex I and suppresses prostaglandin-mediated inflammatory signaling, which may underlie its traditional use for neuralgia and musculoskeletal pain. Additionally, ichthynone has demonstrated smooth muscle relaxant properties in preclinical models, possibly contributing to its antispasmodic and mild hypnotic actions.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on Jamaican Dogwood were identified in the available research. Historical accounts from 1832 describe its medical properties anecdotally, and a 1948 pharmacological investigation exists (PMID: 18905805) but without clinical trial data. Animal studies show anti-inflammatory, sedative, and antispasmodic effects from bark extracts.

Clinical Summary

No published randomized controlled trials in humans have specifically evaluated Jamaican Dogwood for any health indication as of 2024, making its evidence base exclusively traditional and preclinical. In vitro and animal studies have confirmed sedative, antispasmodic, and anti-inflammatory activity of its isoflavonoid and rotenone constituents, but sample sizes, doses, and translational relevance to humans remain unestablished. A small number of older ethnobotanical reports and herbalist case series describe subjective improvements in insomnia and nerve pain at bark extract doses of 1–4 mL of a 1:2 liquid extract, but these lack controls or blinding. The overall evidence strength is very low, and clinicians should treat all purported benefits as preliminary until properly powered human trials are conducted.

Nutritional Profile

Jamaican Dogwood is a medicinal bark herb, not a nutritional food source, so macronutrient content (carbohydrates, protein, fat) is negligible and not nutritionally relevant in typical therapeutic doses. Primary bioactive compounds include: Isoflavonoids — piscidine (ichthynone), jamaicin, milletone, isomilletone, and dehydromilletone, which are the principal pharmacologically active constituents concentrated in the root bark; Rotenoids — rotenone and related compounds present at low but physiologically active concentrations (rotenone estimated at trace levels, <0.1% dry weight in standardized preparations); Organic acids — piscidicacid (also called piscidic acid), a tartaric acid derivative believed to contribute to analgesic and sedative effects, estimated at approximately 0.5–1.5% of dry root bark weight; Alkaloids — trace indeterminate alkaloids reported in older literature but not well characterized; Tannins — present in moderate amounts (~3–8% dry weight), contributing to astringent properties; Glycosides — unspecified flavone glycosides reported in phytochemical screenings; Fiber content is present structurally in bark material but not consumed in whole form (typically used as tincture, extract, or decoction). Micronutrient data (vitamins, minerals) is not established in literature as this herb is not consumed as a food. Bioavailability notes: isoflavonoid and rotenoid compounds are lipophilic and likely better absorbed in alcoholic tincture preparations than aqueous teas; piscidic acid is water-soluble and extractable via decoction. Overall nutritional contribution is considered nil; all relevant activity is phytochemical and pharmacological.

Preparation & Dosage

No clinically studied dosage ranges are available as human trials are absent. Traditional use includes liquid extracts, tinctures, or teas, but lacks standardization details or quantified doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Valerian root, Passionflower, Skullcap, Kava, California poppy

Safety & Interactions

Jamaican Dogwood contains rotenone, a compound with known mitochondrial toxicity at high doses, and chronic or high-dose use has been associated with hepatotoxicity in animal models, warranting caution with prolonged supplementation. It may potentiate the effects of CNS depressants including benzodiazepines, barbiturates, opioids, and alcohol, increasing sedation risk significantly. The herb is contraindicated in pregnancy due to potential uterine stimulant effects observed in animal studies, and it should be avoided by individuals with liver disease or those taking anticoagulants, as rotenone may alter platelet function. People with cardiovascular conditions should also exercise caution, as high doses have produced bradycardia and hypotension in preclinical research.